We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy.
- Authors
Ferrara, F; Morabito, F; Martino, B; Specchia, G; Liso, V; Nobile, F; Boccuni, P; Di Noto, R; Pane, F; Annunziata, M; Schiavone, E M; De Simone, M; Guglielmi, C; Del Vecchio, L; Lo Coco, F
- Abstract
Preliminary reports suggest that leukemic cell expression of CD56, a neural cell adhesion molecule, is associated with adverse clinical outcome in either acute myeloid leukemia with t(8;21) or acute promyelocytic leukemia (APL). We investigated the prognostic relevance of CD56 in a series of patients with APL who were treated homogeneously with all-trans-retinoic acid (ATRA) and chemotherapy.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Vol 18, Issue 6, p1295
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.2000.18.6.1295